A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer diseaseStephen Salloway, Reisa A. Sperling, Ron Keren et al.|Neurology|2011Cited by 255
Evaluation of vertebral fracture assessment by dual X-ray absorptiometry in a multicenter settingThomas Fuerst, B. Mitlak, G.v. Ingersleben et al.|Osteoporosis International|2008Cited by 103